Accelrys, a US-based provider of lifecycle management solutions, has completed the roll-out of its next-generation cheminformatics suite, with the launch of Accelrys Insight and Accelrys Insight for Excel. Both the solutions will help in ...
Tags: lifecycle management, Medicine
Ventana Medical Systems,a member of the Roche Group, and pharmaceutical company Boehringer Ingelheim (BI) have entered into a collaboration agreement for the development of companion diagnostic tests for BI oncology programs. Companion ...
Champions Oncology (Champions), a developer of advanced technology solutions and services to personalize the development and use of oncology drugs, has signed a new discovery and drug development partnership with Teva Pharmaceutical ...
Tags: Champions Oncology
Swedish biotechnology firm Karo Bio (KARO) has achieved its first milestone in a research agreement with Pfizer for the development of drugs for treatment of autoimmune diseases. The achievement of milestone in the RORgamma project ...
The Bill & Melinda Gates Foundation has granted $1.15m funding to a global public-private partnership (PPP), to develop a new pediatric formulation to fight schistosomiasis, commonly known as bilharzia, in preschool children. Formed in ...
Tags: Schistosomiasis Drug, Medicine
Certara, a provider of software and scientific consulting services for drug discovery, has announced the acquisition of Great Lakes Drug Development, a consultancy firm (GLDD) based in Brighton, Michigan. The acquisition is expected to ...
Tags: Certara, Lakes Drug Development
Specialty life-science investment company Torrey Pines Investment (TPI) has signed a multi-million dollar joint investment framework agreement with BioMotiv, a biotech accelerator associated with The Harrington Project for Discovery & ...
Tags: Drug Development, Torrey Pines
US-based drug development services provider Covance has launched a new service offering to its clients to effectively manage contracts in managed markets. The service offering will help biopharmaceutical and medical device clients to ...
Tags: Covance, drug development services
Pharmaceutical research and development company Serina Therapeutics has partnered with the Scripps Research Institute to jointly develop polymer-antibody drug conjugates (Polymer-ADCs). Terms and financial details of the deal have not ...
Tags: Polymer-Antibody Drug, Medicine
Oncology-focused drug development company Curis has obtained the conditional approval for Erivedge (vismodegib) to treat adult patients with symptomatic metastatic basal cell carcinoma (BCC) or locally advanced BCC inappropriate for surgery ...
Purolite, a manufacturer of ion exchange, catalyst, adsorbent and specialty resins, and Codexis, a producer of enzymes, have partnered to develop and commercialize immobilized transaminase enzymes for use in the production of ...
Tags: Transaminase Enzymes, Medicine
Accenture has launched a new business service, known as Accelerated R&D Services, to accelerate drug development from discovery to approval to market. Focused on delivering streamlined and integrated research and development (R&D) ...
Tags: Drugs, R&D Service
Oncology-focused drug development company Curis has secured US patent protecting intellectual property rights of its phosphoinositide 3-kinase (PI3K) - histone deacetylase (HDAC) inhibitor, CUDC-907. The patent covers the method of ...
Tags: Health&Medicine, Curis, US
BD Biosciences, a segment of Becton, Dickinson and Company (BD), has launched BD LSRFortessa X-20 Cell Analyzer, the latest research flow cytometer. The BD LSRFortessa X-20 Cell Analyzer delivers high-performance multicolor analysis and ...
US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...
Tags: Johnson&Johnson, Medicine